English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Pharmaceuticals
+
Pharmaceuticals
Patient Daily
| Jun 14, 2026
Genetic data may improve prediction of steroid side effect risk, study finds
+
Pharmaceuticals
Patient Daily
| Jun 14, 2026
GLP-1 therapy linked to increased dizziness and fainting in patients on blood pressure drugs
+
Pharmaceuticals
Patient Daily
| Jun 14, 2026
New guideline recommends tailored care for children with precocious puberty
+
Pharmaceuticals
Patient Daily
| Jun 14, 2026
Study finds physical activity drops after starting GLP-1 obesity medications
+
Pharmaceuticals
Patient Daily
| Jun 14, 2026
Diabetes increases mortality risk for organ transplant recipients, study finds
+
Pharmaceuticals
Patient Daily
| Jun 14, 2026
Study links longer hormone exposure to increased thyroid cancer risk in women
+
Pharmaceuticals
Patient Daily
| Jun 14, 2026
Study finds hormone-disrupting chemicals in breast milk and infants' urine
+
Pharmaceuticals
Patient Daily
| Jun 14, 2026
Study finds gaps in guideline-based testosterone prescribing practices
Trending
+
Pharmaceuticals
Patient Daily
| Aug 4, 2026
Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+
Pharmaceuticals
Patient Daily
| Aug 6, 2026
FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+
Regulatory
M. Y. Bailey
| Aug 7, 2026
PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports
| Aug 10, 2026
SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
« First
«
…
65
66
67
68
69
70
71
…
»
Last »